Dr. Stephen G O'Brien - CML - Chronic myeloid leukemia


" Stephen O'Brien is a Professor of Haematology at Newcastle University and Honorary Consultant in Haematology at the Newcastle upon Tyne Hospitals NHS Foundation Trust. Following graduation and internal medical experience in Manchester, his training in haematology was undertaken at the Hammersmith Hospital in London where he subsequently completed his PhD under Professor John Goldman. He then worked in Cardiff before settling in Newcastle. He treated the first UK patients to receive Imatinib in September 1999, and continues to be closely involved with ongoing trials with this agent, as well as the newer Tyrosine Kinase Inhibitors. Professor O’Brien is the Chief Investigator for the National Cancer Research Network’s SPIRIT trials in Chronic Myeloid Leukaemia (www.spirit-cml.org), involving approximately 2,000 patients in 150 UK hospitals. Also, he is a member of the NCRI Haem Onc Clinical Studies Group and CML Working Party and the European Leukaemia Network and Vice Chair of NICE Technology Appraisal Committee C."
​Extract of  Northern Institute for Cancer Research, Newcastle University
​


Other links:    Stephen G O'Brien's scientific contributions while affiliated with Newcastle University 
                              Some publications with Dr. G O'Brien
                              Some presentations and notes from ASH meetings
​